Development and validation of rapid molecular diagnostic test for nCoV19

Objectif

Rapid development of a molecular diagnostic test for Corona virus nCoV19 for near patient testing

Champ scientifique

• sciences médicales et de la santé › sciences de la santé › maladie infectieuse › virus à ARN › coronavirus

Programme(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.3. - Treating and managing disease

Thème(s)

• SC1-PHE-CORONAVIRUS-2020 - Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic

Appel à propositions

H2020-SC1-PHE-CORONAVIRUS-2020

Voir d’autres projets de cet appel

Régime de financement

RIA - Research and Innovation action

Coordinateur

HIBERGENE DIAGNOSTICS LIMITED

Contribution nette de l'UE

€ 643 796,25

Adresse

21 Palmerstown Gardens, Rathmines
DUBLIN 6 Dublin
Irlande

Région

Ireland › Eastern and Midland › Dublin

Type d’activité

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Liens

Contribution hors UE

€ 0,00

Participants (3)

THE QUEEN'S UNIVERSITY OF BELFAST

United Kingdom

Contribution nette de l'UE

€ 36 012,50

Adresse

University Road Lanyon Building
BT7 1NN Belfast

Région

Northern Ireland › Northern Ireland › Belfast

Type d’activité

Higher or Secondary Education Establishments

Liens

Contribution hors UE

€ 0,00

IRCCS OSPEDALE POLICLINICO SAN MARTINO

Italie

Contribution nette de l'UE

€ 61 875,00

Adresse

Largo Rosanna Benzi 10
16132 Genova

Région

Nord-Ovest › Liguria › Genova

Type d’activité

Research Organisations

Liens

Contribution hors UE

€ 0,00

SHENZHEN MEDCAPTAIN MEDICAL TECHNOLOGY

Chine

Contribution nette de l'UE

€ 189 921,00

Adresse

5158 West Shahe Road 12th Floor Baiwang Research Bulling 1 Xili Nanshan
518055 Shenzhen

Type d’activité

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Liens

Contribution hors UE

€ 0,00